Cytoskeleton competitorsClear all

Cytoskeleton's top competitors include Biogen, Athersys, Reata Pharmaceuticals and Otonomy.
Cytoskeleton
Cytoskeleton
Cytoskeleton is a company providing kits and products for drug screening, signal transduction, and cytoskeletal research.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Athersys
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Reata Pharmaceuticals
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.
Otonomy
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Founding Date
Founding Date
1993
Founding Date
1978
Founding Date
1995
Founding Date
2002
Founding Date
2008
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Denver, US HQ
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
São Paulo, BR
Mississauga, CA
see more
Locations
Cleveland, US HQ
Canton, US
Locations
Plano, US HQ
Irving, US
Plano, US
Locations
San Diego, US HQ
Employees
Employees
11
Employees
7,4005% decrease
Employees
8311% increase
Employees
22079% increase
Employees
49
Valuation ($)
Valuation ($)
N/A
Valuation ($)
42.4 b
Valuation ($)
379.6 m
Valuation ($)
4 b
Valuation ($)
250.8 m
Twitter followers
Twitter followers
N/A
Twitter followers
36.3 k
Twitter followers
2 k
Twitter followers
1.1 k
Twitter followers
214
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
28
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
15
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
21.5
Average likes per tweet (last 30 days)
27.4
Average likes per tweet (last 30 days)
4.9
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
96.43%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
236270
Alexa Website Rank
254464
Alexa Website Rank
175823
Alexa Website Rank
283162
Alexa Website Rank
339305
Employee Rating
Employee Rating
3.8
Employee Rating
4.1
Employee Rating
4
Employee Rating
3.9
Employee Rating
4.3

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$14.4b (FY, 2019)
Revenue (est.)
$5.6m (FY, 2019)
Revenue (est.)
$26.5m (FY, 2019)
Revenue (est.)
$600k (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
$2b (FY, 2019)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$912k (FY, 2019)
Gross profit
Gross profit
N/A
Gross profit
$12.4b (FY, 2019)
Gross profit
N/A
Gross profit
N/A
Gross profit
($312k) (FY, 2019)
Net income
Net income
N/A
Net income
$5.9b (FY, 2019)
Net income
($44.6m) (FY, 2019)
Net income
($290.2m) (FY, 2019)
Net income
($44.7m) (FY, 2019)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
21 (FY, 2019)
Patents (US)
21 (FY, 2016)
Patents (US)
N/A
Patents (US)
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
34 (FY, 2019)
Patents Issued
200 (FY, 2016)
Patents Issued
240 (FY, 2016)
Patents Issued
88 (FY, 2016)
Patents Pending
Patents Pending
N/A
Patents Pending
N/A
Patents Pending
N/A
Patents Pending
280 (FY, 2016)
Patents Pending
115 (FY, 2016)
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
13 (Q3, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2016)
Phase I Trials Products
1 (FY, 2016)
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
9 (Q3, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2016)
Phase II Trials Products
2 (FY, 2016)
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
6 (Q3, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
1 (FY, 2016)
Phase III Trials Products
2 (FY, 2016)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 9m
Total funding raised
$ 468.9m
Total funding raised
$ 153.4m
For sources of this data, please see the company profile

View company profiles

Biogen
HQ
Cambridge, US
Employees
7,400↓ 5% decrease

Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
Athersys
HQ
Cleveland, US
Employees
83↑ 11% increase

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company
Reata Pharmaceuticals
HQ
Plano, US
Employees
220

Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.

View company
Otonomy
HQ
San Diego, US
Employees
49

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

View company